The Fly on the Wall: Athersys Publishes Study on Increasing Survival of Organ Transplants With Stem Cells

Athersys (ATHX) is a clinical stage based biopharmaceutical company with an exponentially growing pipeline and an array of products in therapeutics to treat significant and life-threatening diseases.

Read more »

Jason Napodano Discusses the “Buzz Word” Regenerative Medicine and Why its a Hot Area in Biotech

Napodano, a senior biotech analyst for Zacks Investment Research discusses 4 regenerative medicine companies making headway in the space.

Read more »

ThermoGenesis to Begin Sale of Novel Stem Cell Device in India

ThermoGenesis said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent.

Read more »

NeoStem to Present Stem Cell Technology at OneMedForum NY 2011

NeoStem , an international biopharmaceutical company, will present at OneMedForum NY 2011.

Read more »